Legal challenges keep US OSH alive while public health experts debate what’s next

Talk of the US Office on Smoking and Health (OSH)’s demise may have been premature. Reports since April indicate that the OSH had its workforce culled as part of personnel and budgetary cuts at its parent organisations, the Centers for Disease Control (CDC) and the Department of Health and Human Services (HHS).

However, recent reports say the dismissal of employees at the OSH and several other HHS entities have been held up by various lawsuits. This means the OSH is not dead yet, but president Donald Trump’s administration appears more and more determined to see through its proposed government downsizing plans – no matter what opposition is placed in its path. As such, it is worth reviewing exactly what the nicotine alternative sector would like to see in a future world post-OSH.

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation